Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Health News Nevada.
Press releases published on June 24, 2025
Fortrea, Emery Pharma와 협력해 FDA 기준에 맞춰 리팜핀 사용 가능한 DDI 연구 지원
GlobeNewswire
·
June 24, 2025
노스캐롤라이나주 더럼, June 24, 2025 (GLOBE NEWSWIRE) -- 글로벌 임상시험수탁기관(CRO) Fortrea(나스닥명: FTRE)(이하 “회사”)가 Emery Pharma와 전략적 협력을 발표했다. Emery Pharma는 현행우수제조관리기준(cGMP)과 우수실험실운영기준(GLP)에 맞춰 테스트 서비스를 제공하며 업계를 선도하는 분석 및 생체시료 분석 CRO로, 약물상호작용(DDI) 연구에서 선호되는 리팜핀을 대상으로 로트별 1-메틸 …
Fortrea และ Emery Pharma ประกาศความร่วมมือเชิงกลยุทธ์เพื่อดำเนินการศึกษาวิจัยอันตรกิริยาระหว่างยาที่สอดคล้องกับ FDA โดยใช้ยาไรแฟมปิน (Rifampin…
GlobeNewswire
·
June 24, 2025
เดอร์แฮม, รัฐนอร์ทแคโรไลนา, June 24, 2025 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE) (“บริษัท”) ซึ่งเป็นองค์กรวิจัยตามสัญญา (Contract Research Organization, CRO) ทางคลินิกชั้นนำระดับโลก ได้ประกาศวันนี้ถึงความร่วมมือเชิงกลยุทธ์กับ Emery Pharma ซึ่งเป็น CRO …
Bioma Probiotics Launches to Address Weight Loss through Microbiome and Digestive Balance
GlobeNewswire
·
June 24, 2025
New York City, June 24, 2025 (GLOBE NEWSWIRE) -- In the world of modern health, one truth stands out: your gut is at the core of almost everything. From digestion and immune health to weight regulation and mood, your gut microbiome plays a massive role in …
Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures
GlobeNewswire
·
June 24, 2025
The future of fracture fixation with novel side-specific nails featuring variable angle locking technology Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of its new TRIGEN MAX Tibia Nailing System for …
Peter Gilgan investing $60 million to build extraordinary at St. Joseph's Health Centre
GlobeNewswire
·
June 24, 2025
PETER GILGAN GIVES DEEPLY PERSONAL GIFT TO ST. JOE’S TORONTO, June 24, 2025 (GLOBE NEWSWIRE) -- Peter Gilgan, founder and CEO of Mattamy Asset Management (the parent company of Mattamy Homes), is paying tribute to his deep roots in Toronto’s west end with …
USAging Announces New Public Awareness Campaign to Raise Visibility of Area Agencies on Aging
GlobeNewswire
·
June 24, 2025
Washington, DC, June 24, 2025 (GLOBE NEWSWIRE) -- USAging is celebrating 50 years as the national organization that represents Area Agencies on Aging (AAAs) and Title VI Native American Aging Programs. As part of the 50th anniversary, USAging has launched …
Rebirth Globe Launches Global Expansion Across the Americas and Middle East, Welcomes International Medical Expert Miss Lucy Yang
GlobeNewswire
·
June 24, 2025
Rebirth Logo NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Rebirth Globe, a pioneering leader in advanced aesthetic device technology, proudly announces its strategic expansion into North America, South America, and the Middle East, marking a transformative …
Actuate Therapeutics Highlights Significant and Sustained Survival Benefit in Key Metastatic Pancreatic Cancer Patient Populations in Phase 2 Elraglusib Trial
GlobeNewswire
·
June 24, 2025
- Near doubling of 1-year overall survival (OS), increased median OS of 4 months (12.5 vs 8.5 months), and 43% reduction in risk of death in patients treated with at least one cycle (4 weeks) of elraglusib plus gemcitabine/nab-paclitaxel (GnP) vs GnP alone …
Progyny Adds Pelvic Floor Therapy, Continuing to Close Gaps in Care Across Women’s Health
GlobeNewswire
·
June 24, 2025
NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced that it is adding pelvic floor therapy to its comprehensive offering of women’s health and family …
Candel Therapeutics Announces $15 million Registered Direct Offering of Common Stock
GlobeNewswire
·
June 24, 2025
NEEDHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, has …
Innovate GBM Rings the NASDAQ Closing Bell in Honor of Brain Tumor Patients and Community
GlobeNewswire
·
June 24, 2025
LOS ANGELES, June 24, 2025 (GLOBE NEWSWIRE) -- Innovate GBM, a 501(c)(3) nonprofit organization dedicated to transforming the future of brain tumor research and treatment through collaboration, infrastructure, and strategic investment, rang the NASDAQ …
Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program
GlobeNewswire
·
June 24, 2025
Priothera Secures €1.7 million i-Nov Funding by Bpifrance for Rare Blood Cancer Clinical Program Funding to support MOCART, a clinical programme evaluating mocravimod added to standard CAR-T cell therapy Saint-Louis, France and Dublin, Ireland – 24 June …
Green Tree Pediatrics is Now Part of the Zarminali Pediatrics, Signaling New Chapter of Care and Community Commitment
GlobeNewswire
·
June 24, 2025
ANN ARBOR, Mich., June 24, 2025 (GLOBE NEWSWIRE) -- Zarminali Pediatrics, the first outpatient pediatric destination purpose-built to provide elevated, seamlessly coordinated primary and specialty care nationwide, announced that Green Tree Pediatrics has …
Capricor Therapeutics Provides Regulatory Update on Deramiocel BLA for Duchenne Muscular Dystrophy
GlobeNewswire
·
June 24, 2025
FDA has indicated that an Advisory Committee meeting is not required at this time In-person late-cycle review meeting scheduled for mid-July Biologics License Application (BLA) remains under Priority Review with PDUFA target action date of August 31, 2025 …
Senti Bio to Present at the 2025 Synthetic Biology: Engineering, Evolution, & Design (SEED) Conference
GlobeNewswire
·
June 24, 2025
SOUTH SAN FRANCISCO, Calif., June 24, 2025 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (Nasdaq: SNTI) (“Senti Bio” or the “Company”), a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene …
CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer
GlobeNewswire
·
June 24, 2025
VANCOUVER, Washington, June 24, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that …
Cellectar Biosciences Submits Phase 1b Clinical Trial Protocol to US Food and Drug Administration for CLR 125 to Treat Triple-Negative Breast Cancer (TNBC)
GlobeNewswire
·
June 24, 2025
Good Tolerability and Robust Tumor Uptake were Observed in TNBC Animal Models Auger Emitters Offer the Potential Benefit of Enhanced Cytotoxicity, Safety and Ease-of-Use FLORHAM PARK, N.J., June 24, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. ( …
Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic & Financial Performance Transformation
GlobeNewswire
·
June 24, 2025
Strategic Offshore Manufacturing Move Expected to Drive Gross Margin Expansion, Free Up Working Capital, and Enhance Scalability Transition to Outsourced Production Reduces Fixed Costs and Supports Trinity’s Broader Profitability and Growth Objectives …
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹⁶¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
GlobeNewswire
·
June 24, 2025
RAD 402 preclinical data package complete; demonstrates safety and promising biodistribution profile Ethics approval and Phase 1 clinical trial start in prostate cancer anticipated in 2H 2025 SYDNEY and BUNDOORA, Australia, June 24, 2025 (GLOBE NEWSWIRE) …
Starton Therapeutics and Bend Bioscience Enter into Development Agreement for Oral Controlled Release Dosage Form of STAR-LLD (lenalidomide)
GlobeNewswire
·
June 24, 2025
PARAMUS, N.J., June 24, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. (“Starton”), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technologies, today announced a collaboration …